BIOPORTO A/S

BIOPOR
Delayed Quote. Delayed  - 10/20 10:59:49 am
4DKK +6.10%

Turn to zoom
Prev.3.7700
Open3.8600
High4.1000
Low3.8500
Volume1 372 879
Latest news
13h ago
19h ago
19h ago
19h ago
Chart BIOPORTO A/S
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance4,304,924,16
Spread/Res.-7,0%-19%-3,7%
Spread/Supp.17%48%44%
Support3,432,712,79
Financials
Sales 2021 30,2 M 4,73 M 4,73 M
Net income 2021 -63,1 M -9,89 M -9,89 M
Net Debt 2021 - - -
P/E ratio 2021 -16,7x
Yield 2021 -
Capitalization 1 071 M 168 M 168 M
Capi. / Sales 2021 35,5x
Capi. / Sales 2022 9,95x
Nbr of Employees 29
Free-Float 100%
Company
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL...

>> Read more
Sector :
Diagnostic & Testing Substances
Calendar :
2021-11-17 Earnings Release
Trading Rating : -
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 4,00 DKK
Average target price 6,00 DKK
Spread / Average Target 50,0%